927PClinical outcomes by sex with atezolizumab (atezo) monotherapy in patients (pts) with locally advanced/metastatic urothelial carcinoma (mUC)

Hoffman-Censits, J ; Rosenberg, J E ; van Der Heijden, M ; Dreicer, R ; Perez Gracia, J L ; Petrylak, D P ; Retz, M M ; Sabbatini, R ; Naglieri, E ; Caserta, C ; Maruzzo, M ; Iacovelli, R ; Galli, L ; McDermott, R ; Morales Barrera, R ; Bonfill, T ; De Ducla, S ; Ding, B ; Linsenmeier, J ; Sternberg, C N

Oxford University Press

Texto completo disponível

927P - Clinical outcomes by sex with atezolizumab (atezo) monotherapy in patients (pts) with locally advanced/metastatic urothelial carcinoma (mUC)

Hoffman-Censits, J. ; Rosenberg, J.E. ; van Der Heijden, M. ; Dreicer, R. ; Perez Gracia, J.L. ; Petrylak, D.P. ; Retz, M.M. ; Sabbatini, R. ; Naglieri, E. ; Caserta, C. ; Maruzzo, M. ; Iacovelli, R. ; Galli, L. ; McDermott, R. ; Morales Barrera, R. ; Bonfill, T. ; De Ducla, S. ; Ding, B. ; Linsenmeier, J. ; Sternberg, C.N.

Elsevier Ltd

Texto completo disponível

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Knox, J J ; Barrios, C H ; Kim, T M ; Cosgriff, T ; Srimuninnimit, V ; Pittman, K ; Sabbatini, R ; Rha, S Y ; Flaig, T W ; Page, R D ; Beck, J T ; Cheung, F ; Yadav, S ; Patel, P ; Geoffrois, L ; Niolat, J ; Berkowitz, N ; Marker, M ; Chen, D ; Motzer, R J

England: Oxford University Press

Texto completo disponível

Corrections to Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Knox, J.J. ; Barrios, C.H. ; Kim, T.M. ; Cosgriff, T. ; Srimuninnimit, V. ; Pittman, K. ; Sabbatini, R. ; Rha, S.Y. ; Flaig, T.W. ; Page, R.D. ; Beck, J.T. ; Cheung, F. ; Yadav, S. ; Patel, P. ; Geoffrois, L. ; Niolat, J. ; Berkowitz, N. ; Marker, M. ; Chen, D. ; Motzer, R.J.

Elsevier Ltd

Texto completo disponível

Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters—patient-centered end points in trials of maintenance therapy

Friedlander, M. ; Rau, J. ; Lee, C.K. ; Meier, W. ; Lesoin, A. ; Kim, J.-W. ; Poveda, A. ; Buck, M. ; Scambia, G. ; Shimada, M. ; Hilpert, F. ; King, M.T. ; Debruyne, P. ; Bologna, A. ; Malander, S. ; Monk, B.J. ; Petru, E. ; Calvert, P. ; Herzog, T.J. ; Barrett, C. ; du Bois, A.

England: Elsevier Ltd

Texto completo disponível

Efficacy and safety data in elderly patients (pts) with metastatic renal cell carcinoma (mRCC) included in the nivolumab expanded access program (EAP) in Italy

Sabbatini, R. ; Galli, L. ; Pignata, S. ; Lo Re, G. ; Valcamonico, F. ; Defferrari, C. ; Spada, M. ; Santini, D. ; Masini, C. ; Ciuffreda, L. ; Ruggeri, E.M. ; Chioni, A. ; Livi, L. ; Fagnani, D. ; Bonetti, A. ; Giustini, L. ; Duranti, S. ; Procopio, G. ; Caserta, C. ; Cartenì, G.

Elsevier Ltd

Texto completo disponível

Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC

Knox, J.J. ; Barrios, C.H. ; Kim, T.M. ; Cosgriff, T. ; Srimuninnimit, V. ; Pittman, K. ; Sabbatini, R. ; Rha, S.Y. ; Flaig, T.W. ; Page, R.D. ; Beck, J.T. ; Cheung, F. ; Yadav, S. ; Patel, P. ; Geoffrois, L. ; Niolat, J. ; Berkowitz, N. ; Marker, M. ; Chen, D. ; Motzer, R.J.

England: Elsevier Ltd

Texto completo disponível

Outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequence in post-docetaxel (DOC) setting. An updated analysis from a multicenter Italian study

Caffo, O. ; Biasco, E. ; Facchini, G. ; Fratino, L. ; Gasparro, D. ; Mosillo, C. ; Basso, U. ; Santini, D. ; Tucci, M. ; Ortega, C. ; Verderame, F. ; Scagliarini, S. ; Re, G.L.o. ; Procopio, G. ; Fornarini, G. ; Campadelli, E. ; Sabbatini, R. ; Maines, F. ; De Giorgi, U.

Elsevier Ltd

Texto completo disponível

Retrospective observational study of Vinflunine (VFL) in patients (pts) with transitional cell carcinoma of the urothelial tract (TCCU): final results of a real world population study (MOVIE-GOIRC01/2014 trial)

Passalacqua, R. ; Lazzarelli, S. ; Montironi, R. ; Pignata, S. ; De Giorgi, U. ; Bernardo, A. ; Ceresoli, G.L. ; Delconte, G. ; Donini, M. ; Iezzi, E. ; Maiello, E. ; Nolè, F. ; Panni, S. ; Perrucci, B. ; Rondini, E. ; Sabbatini, R. ; Sequino, M. ; Tonini, G. ; Zucali, P. ; Caminiti, C.

Texto completo disponível

Outcome of patients with multiple glandular metastases from renal cell carcinoma treated with targeted agents

Grassi, P. ; Grunwald, V. ; Melichar, B. ; Galli, L. ; De Giorgi, U. ; Sabbatini, R. ; Ortega, C. ; Santoni, M. ; Derosa, L. ; Porcu, L. ; Ratta, R. ; Mennitto, A. ; Verzoni, E. ; de Braud, F. ; Porta, C. ; Escudier, B. ; Procopio, G.

Texto completo disponível